Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy
about
Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy.Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.
P2860
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en-gb
type
label
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en-gb
prefLabel
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en-gb
P2093
P2860
P1476
Definitive Management of Oligo ...... herapy and Viral Immunotherapy
@en
P2093
Hardev Pandha
Jill Thompson
Karishma Rajani
Keith M Furutani
Kenneth R Olivier
Kevin G Shim
Kevin Harrington
Michael P Grams
Miran Blanchard
Richard Vile
P2860
P304
P356
10.1016/J.IJROBP.2015.07.2274
P407
P577
2015-07-26T00:00:00Z